Report Overview: The Global Opioids Drugs Market achieved a valuation of $18.96 Billion in 2022 and is anticipated to exceed $23.65 Billion by 2030, reflecting a compounded annual growth rate (CAGR) of 2.96% during the forecast period from 2024 to 2032. Key Market Players: Allergan, Orexo Pharmaceuticals, Purdue Pharma, Pfizer, AbbVie, Teva pharmaceuticals, Johnson & Johnson,...